These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3847520)

  • 21. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1983 Mar; 36(3):481-6. PubMed ID: 6876360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
    Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Sato K; Fukumoto T
    Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
    Ploechl E; Huber EG
    J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential intravenous-oral amoxycillin/clavulanate (Augmentin) therapy in paediatric hospital practice.
    Schaad UB; Pfenninger J; Wedgewood-Krucko J
    J Antimicrob Chemother; 1987 Mar; 19(3):385-91. PubMed ID: 3571053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
    Weber DJ; Tolkoff-Rubin NE; Rubin RH
    Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
    [No Abstract]   [Full Text] [Related]  

  • 31. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
    Focht J; Klietmann W; Heilmann HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pediatric suspensions of amoxicillin and clavulanic acid in the treatment of bacterial infections of otorhinolaryngologic importance and the upper respiratory tract].
    Amendola F; Natuzzi M; De Mattia D; Schettini F
    Minerva Pediatr; 1989 Feb; 41(2):97-103. PubMed ID: 2786988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibacterial activity for clinical isolates from pediatric patients of clavulanic acid/amoxicillin (1: 14) -outcomes of special drug use investigation on antibacterial activity (annual changes)].
    Ishida A; Hasegawa N; Okano H; Hara T; Yoshida P
    Jpn J Antibiot; 2013 Jun; 66(3):141-58. PubMed ID: 24167843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
    Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentin in acute exacerbations of chronic bronchitis.
    Aigner K; Schindl R; Mittermayer H
    J Int Med Res; 1984; 12(6):321-6. PubMed ID: 6335111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes.
    Boon RJ; Beale AS
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1204-9. PubMed ID: 3307617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
    Feldman W; Sutcliffe T; Dulberg C
    CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.